These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2859542)

  • 1. Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats.
    Gaffori O; Van Ree JM
    Neuropharmacology; 1985 Mar; 24(3):237-44. PubMed ID: 2859542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-endorphin-(10-16) antagonizes behavioral responses elicited by melatonin following injection into the nucleus accumbens of rats.
    Gaffori O; van Ree JM
    Life Sci; 1985 Jul; 37(4):357-64. PubMed ID: 3159948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs.
    Durlach-Misteli C; Van Ree JM
    Eur J Pharmacol; 1992 Jun; 217(1):15-21. PubMed ID: 1397023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nucleus accumbens and antidepressants: modulation of ergometrine-induced hyperactivity by typical and atypical antidepressants and neuroleptics in rats.
    Cools AR
    Psychopharmacology (Berl); 1987; 92(3):350-7. PubMed ID: 2888148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Király I; Van Ree JM
    Neuropharmacology; 1984 May; 23(5):511-6. PubMed ID: 6204246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and beta-endorphin-(10-16), like antidepressants, antagonize melatonin-induced behavioural changes in rats.
    Hatta K; Wolterink G; Van Ree JM
    Eur J Pharmacol; 1995 Sep; 284(3):327-30. PubMed ID: 8666016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
    Van Ree JM; Gaffori O; De Wied D
    Eur J Pharmacol; 1983 Sep; 93(1-2):63-78. PubMed ID: 6138272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
    Dourish CT
    Br J Pharmacol; 1982 Sep; 77(1):129-39. PubMed ID: 6982090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-opiate beta-endorphin fragments and dopamine--III. gamma-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injection of apomorphine into the nucleus accumbens.
    Van Ree JM; Caffé AR; Wolterink G
    Neuropharmacology; 1982 Nov; 21(11):1111-7. PubMed ID: 6184640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typical and atypical antidepressant drug effects on locomotor activity after intra-accumbens injections in the rat.
    Oosterloo SK; Cools AR
    Eur J Pharmacol; 1985 Nov; 118(1-2):45-51. PubMed ID: 4085549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LSD mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility.
    Fink H; Oelssner W
    Eur J Pharmacol; 1981 Nov; 75(4):289-96. PubMed ID: 7318915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine--a serotonin antagonist?
    Fink H; Morgenstern R; Oelssner W
    Pharmacol Biochem Behav; 1984 Apr; 20(4):513-7. PubMed ID: 6728869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    J Neural Transm; 1984; 60(3-4):273-82. PubMed ID: 6241227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area.
    Gillies DM; Mylecharane EJ; Jackson DM
    Eur J Pharmacol; 1996 May; 303(1-2):1-12. PubMed ID: 8804905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of antipsychotics on presynaptic receptors modulating the release of dopamine in synaptosomes of the nucleus accumbens of rats.
    Hetey L; Drescher K
    Neuropharmacology; 1986 Oct; 25(10):1103-9. PubMed ID: 2878387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.